Suppr超能文献

在北美的肝素诱导的血小板减少症的能力验证结果。

Proficiency testing results for heparin-induced thrombocytopenia in north america.

机构信息

Department of Pathology and ARUP Laboratories Institute for Clinical and Experiment Pathology, ARUP Laboratories, University of Utah, Salt Lake City, Utah.

CLOT-ED, Inc., Islamorada, Florida.

出版信息

Semin Thromb Hemost. 2014 Mar;40(2):254-60. doi: 10.1055/s-0034-1365842. Epub 2014 Feb 4.

Abstract

Between 2010 and 2012, North American Specialized Coagulation Laboratory Association (NASCOLA) distributed five proficiency testing challenges to evaluate laboratory testing for heparin-induced thrombocytopenia (HIT). Results (n = 355) were submitted from 43 unique laboratories for 10 samples (3 positive, 2 weak positive, and 5 negative). The vast majority of results were from commercial enzyme-linked immunosorbent assay (ELISA) methods, predominantly polyvalent assays. Laboratories performed well in the classification of clear negative and positive samples. All results (100%) submitted for the five negative samples (n = 173) and 97% of immunological results submitted for the three positive samples (n = 105) were correctly classified (the incorrect responses were two borderline classifications and, from a gel-agglutination method, one negative classification). There was more difficulty in the classification of the two weak positive samples (n = 70). In one survey, 61% of results from the weak positive sample were classified as positive, while 21% were called negative, 16% were called borderline, and 2% were called inconclusive. In a second survey, 16% of results from the weak positive sample were called positive, while 56% were called negative, and 28% were called borderline. Significant interlaboratory variation was observed for ELISA results, with coefficients of variation of about 20 to 30%. We conclude that there is variability in HIT laboratory testing and that identification of weak positive samples can be challenging.

摘要

2010 年至 2012 年期间,北美专业凝血实验室协会(NASCOLA)分发了五项能力验证测试,以评估用于肝素诱导的血小板减少症(HIT)的实验室检测。来自 43 个不同实验室的 10 个样本(3 个阳性、2 个弱阳性和 5 个阴性)提交了结果。绝大多数结果来自商业酶联免疫吸附测定(ELISA)方法,主要是多价测定法。实验室在明确阴性和阳性样本的分类方面表现良好。五个阴性样本(n = 173)提交的所有结果(100%)和三个阳性样本(n = 105)提交的免疫结果的 97%均得到正确分类(不正确的反应是两种边界分类,以及来自凝胶凝集法的一个阴性分类)。在两种弱阳性样本(n = 70)的分类中遇到了更多困难。在一项调查中,弱阳性样本的 61%的结果被分类为阳性,而 21%被归类为阴性,16%被归类为边界,2%被归类为不确定。在第二项调查中,弱阳性样本的 16%的结果被归类为阳性,而 56%被归类为阴性,28%被归类为边界。ELISA 结果的实验室间变异显著,变异系数约为 20%至 30%。我们得出结论,HIT 实验室检测存在变异性,识别弱阳性样本具有挑战性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验